© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Quest Diagnostics Incorporated (DGX) stock declined over -1.41%, trading at $191.42 on NYSE, down from the previous close of $194.16. The stock opened at $193.17, fluctuating between $191.04 and $194.28 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 14, 2026 | 192.27 | 194.26 | 191.16 | 194.16 | 831.45K |
| Apr 13, 2026 | 191.03 | 193.13 | 189.72 | 192.91 | 899K |
| Apr 10, 2026 | 197.66 | 197.66 | 190.12 | 191.51 | 847.19K |
| Apr 09, 2026 | 197.93 | 199.41 | 196.55 | 197.82 | 718.36K |
| Apr 08, 2026 | 196.18 | 198.89 | 194.02 | 198.81 | 779.83K |
| Apr 07, 2026 | 199.49 | 201.00 | 195.70 | 196.81 | 905.41K |
| Apr 06, 2026 | 196.87 | 199.22 | 196.57 | 198.96 | 477.84K |
| Apr 02, 2026 | 196.66 | 199.14 | 196.06 | 198.02 | 519.92K |
| Apr 01, 2026 | 195.51 | 198.86 | 194.09 | 197.69 | 559.13K |
| Mar 31, 2026 | 194.86 | 198.95 | 192.73 | 195.98 | 1.27M |
| Mar 30, 2026 | 196.67 | 197.56 | 194.72 | 197.16 | 830.75K |
| Mar 27, 2026 | 197.93 | 198.63 | 194.57 | 195.51 | 976.31K |
| Mar 25, 2026 | 196.77 | 197.72 | 194.28 | 196.46 | 675.52K |
| Mar 24, 2026 | 194.58 | 197.03 | 193.81 | 196.08 | 757.44K |
| Mar 23, 2026 | 197.33 | 202.91 | 195.23 | 195.60 | 881.02K |
| Mar 20, 2026 | 194.07 | 196.83 | 192.79 | 195.26 | 1.96M |
| Mar 19, 2026 | 195.01 | 197.21 | 193.91 | 194.16 | 801.8K |
| Mar 18, 2026 | 197.07 | 201.49 | 194.88 | 195.23 | 694K |
| Mar 17, 2026 | 200.70 | 200.70 | 197.18 | 198.61 | 791.29K |
| Mar 16, 2026 | 200.98 | 201.88 | 198.86 | 198.94 | 776.21K |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| Employees | 55000 |
| Beta | 0.65 |
| Sales or Revenue | $9.87B |
| 5Y Sales Change% | 0.492% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |